Company Management

Cyclo Therapeutics, Inc.

Pharmaceutical Manufacturing Gainesville, Florida, United States 19 employees

Employees: 19
Contacts: 1
Emails: 1
Phones: 1

ctd-holdings.com LinkedIn Crunchbase

Cyclo Therapeutics, Inc. Overview

Headquarters: Gainesville, Florida, United States
Website: ctd-holdings.com
Industry: Pharmaceutical Manufacturing
Employees: 19
Founded: 1990
Funding: 2.5M
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

cyclodextrins cyclodextrin derivatives cyclodextrin complexes cyclodextrin chemistry hydroxypropyl gamma Trappsol(R) Cyclo(TM) Aquaplex(R)

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C, a rare and fatal genetic disease, (www.ClinicalTrials.gov NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is conducting a Phase 2b clinical trial using Trappsol® Cyclo™ intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842). Additional indications for the active ingredient in Trappsol® Cyclo™ are in development. For additional information, visit the Company’s website: www.cyclotherapeutics.com.

Cyclo Therapeutics, Inc. Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage
Phone contacts: 1; 25.0% coverage

Cyclo Therapeutics, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mike Lisjak		United States	View
Rachel Cunningham, Pharmd	Dedicated to Supporting Patients		View
Jeffrey Tate	COO, & Cqo at Cyclo Therapeutics, Llc	Gainesville, Florida, United States	Email Phone
Edward Tumaian	SVP Clinical Operations		View